• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)

    Gabrielle Lakusta
    Feb. 22, 2018 09:34AM PST
    Medical Device Investing

    LeMaitre Vascular (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share. As quoted in the press release: Record sales of $26.2mm, +12% vs. Q4 2016 Record operating income of $6.3mm vs. $3.9mm, +62% Net income of $4.3mm vs. $2.6mm, +65% Earnings of $0.21 per diluted …

    LeMaitre Vascular (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share.

    As quoted in the press release:

    • Record sales of $26.2mm, +12% vs. Q4 2016
    • Record operating income of $6.3mm vs. $3.9mm, +62%
    • Net income of $4.3mm vs. $2.6mm, +65%
    • Earnings of $0.21 per diluted share vs. $0.13, +60%
    • Record EBITDA of $7.4mm vs. $4.8mm, +55%

    Click here to read the full press release.

    lemaitre vascularq4 2016medical device investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Merck Announces First-Quarter 2023 Financial Results

    Merck Announces First-Quarter 2023 Financial Results

    Viemed Healthcare Announces Second Quarter 2021 Financial Results

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cardiex Limited

    CDX:AU

    Cleo Diagnostics

    COV:AU

    Ocumetics Technology

    OTC:CA

    Premier Health of America

    PHA:CA

    Bloom Health Partners

    BLMH:CNX

    Applied UV

    AUVI:NSD
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES